• / Free eNewsletters & Magazine
  • / My Account

High Risk

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. UPDATE: Women, get real: Here's the new feminists' manifesto

    UPDATE: Women, get real: Here's the new feminists' manifesto

  2. InspireMD to Host Conference Call and Webinar and to Discuss Recently Released Results of CGuard™ CARENET Trial on September 24th

    InspireMD to Host Conference Call and Webinar and to Discuss Recently Released Results of CGuard™ CARENET Trial on September 24th

  3. Pathway Genomics Announces Commitment to Free the Data Movement at NSGC Conference

    Pathway Genomics Announces Commitment to Free the Data Movement at NSGC Conference

  4. Alberta Investment Management wins SimCorp StrategyLab Risk Management Excellence Award

    Alberta Investment Management wins SimCorp StrategyLab Risk Management Excellence Award

  5. UPDATE: Family Dollar tells Dollar General 'no' means 'no'

    UPDATE: Family Dollar tells Dollar General 'no' means 'no'

  6. Research and Markets: Asia Pacific NIPT Market Outlook 2018

    Research and Markets: Asia Pacific NIPT Market Outlook 2018

  7. UPDATE: Scotland ready to call London's bluff over sterling

    UPDATE: Scotland ready to call London's bluff over sterling

  8. UPDATE: Low volatility is a sign of high risk -taking, BIS official says

    UPDATE: Low volatility is a sign of high risk -taking, BIS official says

  9. UPDATE: Low volatility is a sign of high risk -taking, BIS official says

    UPDATE: Low volatility is a sign of high risk -taking, BIS official says

  10. Amgen Announces Results From Several New Exploratory Analyses Evaluating Long-Term Impact Of Treatment With Prolia® (Denosumab) In Postmenopausal Women With Osteoporosis

    Amgen Announces Results From Several New Exploratory Analyses Evaluating Long-Term Impact Of Treatment With Prolia® (Denosumab) In Postmenopausal Women With Osteoporosis

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.